DEUTSCHE BANK AG\ - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$451,000
+162.2%
99,860
+185.1%
0.00%
Q4 2020$172,000
+12.4%
35,031
+35.9%
0.00%
Q3 2020$153,000
+188.7%
25,772
+29.4%
0.00%
Q2 2020$53,000
+96.3%
19,915
+46.3%
0.00%
Q1 2020$27,000
-59.7%
13,617
+40.7%
0.00%
Q4 2019$67,000
-8.2%
9,675
+28.3%
0.00%
Q3 2019$73,000
-68.1%
7,539
-62.7%
0.00%
Q2 2019$229,000
-33.8%
20,221
-41.5%
0.00%
Q1 2019$346,000
+208.9%
34,578
+415.8%
0.00%
Q4 2018$112,000
-77.4%
6,704
-76.3%
0.00%
Q3 2018$495,00028,2870.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders